ARTICLE | Clinical News
Egalet-002 regulatory update
February 24, 2014 8:00 AM UTC
Egalet said FDA granted Fast Track designation to Egalet-002 to treat moderate to severe pain. The abuse-deterrent, extended-release, oral formulation of oxycodone is being developed under section 505...